EmbodyBio

EmbodyBio is a pioneer in developing digital twin platforms for precision medicine, precision health, and biopharmaceutical research. EmbodyBio collaborates with leading academic institutions to analyze longitudinal multi-omics datasets for identifying and characterizing inputs into their "Bio-Digital Twin Platform." The company’s current focus is on its digital twin platform for brain health and neurodegenerative diseases, with applications in healthy aging, Alzheimer's disease, Parkinson's disease, and multiple sclerosis.